Delivery Order SPE2DB22D2108-SPE2DB25FU5RE
- Not listed
- The Defense Logistics Agency awarded a $3,549.93 delivery order to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets (30-count unit dose packaging) on August 19, 2025, with completion scheduled for August 20, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The delivery location is specified as Conshohocken, PA, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,083.49 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30 count) under a firm fixed price contract. This delivery order, which was competitively awarded with no set-aside designation, was executed on July 23, 2025, with an ultimate completion date of July 24, 2025. Performance will take place at the contractor's Corporate Office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $2,833.03 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 1, 2025, with an ultimate completion date of August 4, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,021.48 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price delivery order was issued on August 20, 2025, with an ultimate completion date of August 21, 2025. The contract requires performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $3,369.69 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count). This contract, issued on August 27, 2025, with completion targeted for August 28, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating open competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,314.14 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-25 mg tablets in unit dose packaging (30-count packages). The contract, executed on August 18, 2025, with an ultimate completion date of August 19, 2025, is structured as a firm fixed price delivery order with no set-aside designation. This award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $3,211.89 to AmerisourceBergen Drug Corp for Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) on August 28, 2025, with completion targeted for August 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The contract represents a single transaction under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,002.44 to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30 count). This is a firm fixed price, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of August 28, 2025. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $4,426.24 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count) with a firm fixed price structure. The contract was awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,215.19 on August 22, 2025, for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in unit dose packaging (30-count). This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical product will be...
- SPE2DB22D2108Indefinite Delivery Contract
- SPE2DB22D2108-SPE2DB25FU5REDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,249.93 to AmerisourceBergen Drug Corp for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in unit dose packaging (30-count). The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, under a firm fixed price contract type with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The SPE2DX IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Through this contract vehicle, the company delivers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order for Telmisartan-HCTZ, an antihypertensive combination medication, exemplifies the routine pharmaceutical procurement conducted under this master contract to support federal military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/2/25 |